Biovie Book Value per Share vs Working Capital Analysis

BIVI Stock

USD 0.47 0.02 4.08%

Biovie financial indicator trend analysis is way more than just evaluating Biovie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biovie Inc is a good investment. Please check the relationship between Biovie Book Value Per Share and its Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Book Value Per Share vs Working Capital

Book Value per Share vs Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biovie Inc Book Value per Share account and Working Capital. At this time, the significance of the direction appears to have no relationship.

The correlation between Biovie's Book Value per Share and Working Capital is 0.0. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Working Capital in the same time period over historical financial statements of Biovie Inc, assuming nothing else is changed. The correlation between historical values of Biovie's Book Value per Share and Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of Biovie Inc are associated (or correlated) with its Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Working Capital has no effect on the direction of Book Value per Share i.e., Biovie's Book Value per Share and Working Capital go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Most indicators from Biovie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biovie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

As of now, Biovie's Selling General Administrative is increasing as compared to previous years. The Biovie's current Issuance Of Capital Stock is estimated to increase to about 66.9 M, while Enterprise Value Over EBITDA is projected to decrease to (2.88).

	2021	2023	2024 (projected)
Interest Expense	2.2M	4.9M	5.2M
Depreciation And Amortization	273.5K	263.8K	189.7K

Interest Expense Depreciation And Amortization

Biovie fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Net Tangible Assets	Common Stock Shares Outstanding	Non Current Assets Total	Non Currrent Assets Other	Good Will	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Net Invested Capital	Net Working Capital
Total Assets		0.68	0.78	-0.79	-0.89	-0.34	0.98	1.0	-0.33	0.76	0.94	0.81	1.0	-0.29	0.22	0.77	0.99	0.08	-0.12	0.5	0.19	-0.02	0.92	-0.5	0.92	0.86
Total Current Liabilities	0.68		0.1	-0.34	-0.58	0.18	0.61	0.67	-0.39	0.41	0.6	0.94	0.67	-0.37	0.84	0.09	0.68	0.16	-0.13	0.49	0.6	0.09	0.58	-0.53	0.36	0.21
Total Stockholder Equity	0.78	0.1		-0.69	-0.67	-0.58	0.75	0.79	-0.08	0.52	0.75	0.27	0.78	-0.05	-0.43	1.0	0.74	-0.05	-0.06	0.23	-0.27	-0.1	0.74	-0.2	0.95	0.96
Net Debt	-0.79	-0.34	-0.69		0.95	0.31	-0.88	-0.79	0.35	-0.83	-0.92	-0.57	-0.79	0.33	-0.04	-0.69	-0.86	0.02	0.19	-0.4	-0.11	0.13	-0.93	0.44	-0.79	-0.82
Retained Earnings	-0.89	-0.58	-0.67	0.95		0.15	-0.93	-0.88	0.41	-0.78	-0.98	-0.74	-0.88	0.38	-0.25	-0.66	-0.94	-0.09	0.15	-0.55	-0.24	0.03	-0.98	0.59	-0.81	-0.78
Accounts Payable	-0.34	0.18	-0.58	0.31	0.15		-0.38	-0.38	0.03	-0.36	-0.22	0.01	-0.38	0.01	0.47	-0.63	-0.28	0.58	0.28	0.47	0.46	0.59	-0.18	-0.49	-0.55	-0.6
Cash	0.98	0.61	0.75	-0.88	-0.93	-0.38		0.98	-0.36	0.87	0.96	0.8	0.98	-0.33	0.2	0.75	0.99	0.03	-0.14	0.46	0.18	-0.08	0.94	-0.49	0.91	0.88
Cash And Short Term Investments	1.0	0.67	0.79	-0.79	-0.88	-0.38	0.98		-0.34	0.76	0.94	0.8	1.0	-0.31	0.2	0.78	0.98	0.01	-0.13	0.44	0.16	-0.08	0.92	-0.46	0.93	0.87
Common Stock Total Equity	-0.33	-0.39	-0.08	0.35	0.41	0.03	-0.36	-0.34		-0.29	-0.39	-0.42	-0.34	1.0	-0.34	-0.1	-0.36	0.17	0.41	0.0	0.34	0.21	-0.38	-0.03	-0.21	-0.17
Non Current Liabilities Total	0.76	0.41	0.52	-0.83	-0.78	-0.36	0.87	0.76	-0.29		0.77	0.68	0.76	-0.27	0.17	0.51	0.8	0.09	-0.07	0.43	0.18	-0.01	0.76	-0.46	0.71	0.73
Other Stockholder Equity	0.94	0.6	0.75	-0.92	-0.98	-0.22	0.96	0.94	-0.39	0.77		0.76	0.94	-0.36	0.2	0.74	0.98	0.08	-0.15	0.53	0.2	-0.03	1.0	-0.56	0.88	0.84
Total Liab	0.81	0.94	0.27	-0.57	-0.74	0.01	0.8	0.8	-0.42	0.68	0.76		0.81	-0.4	0.73	0.26	0.83	0.16	-0.13	0.55	0.54	0.06	0.73	-0.59	0.54	0.43
Total Current Assets	1.0	0.67	0.78	-0.79	-0.88	-0.38	0.98	1.0	-0.34	0.76	0.94	0.81		-0.31	0.21	0.78	0.98	0.02	-0.13	0.45	0.17	-0.08	0.92	-0.47	0.93	0.87
Common Stock	-0.29	-0.37	-0.05	0.33	0.38	0.01	-0.33	-0.31	1.0	-0.27	-0.36	-0.4	-0.31		-0.33	-0.07	-0.33	0.17	0.41	0.02	0.35	0.21	-0.35	-0.04	-0.18	-0.15
Other Current Liab	0.22	0.84	-0.43	-0.04	-0.25	0.47	0.2	0.2	-0.34	0.17	0.2	0.73	0.21	-0.33		-0.43	0.26	0.18	-0.12	0.37	0.7	0.12	0.19	-0.41	-0.16	-0.28
Net Tangible Assets	0.77	0.09	1.0	-0.69	-0.66	-0.63	0.75	0.78	-0.1	0.51	0.74	0.26	0.78	-0.07	-0.43		0.73	-0.13	-0.08	0.16	-0.29	-0.19	0.73	-0.15	0.95	0.96
Common Stock Shares Outstanding	0.99	0.68	0.74	-0.86	-0.94	-0.28	0.99	0.98	-0.36	0.8	0.98	0.83	0.98	-0.33	0.26	0.73		0.06	-0.14	0.51	0.24	-0.04	0.97	-0.54	0.9	0.84
Non Current Assets Total	0.08	0.16	-0.05	0.02	-0.09	0.58	0.03	0.01	0.17	0.09	0.08	0.16	0.02	0.17	0.18	-0.13	0.06		0.18	0.86	0.33	0.99	0.09	-0.63	-0.04	-0.05
Non Currrent Assets Other	-0.12	-0.13	-0.06	0.19	0.15	0.28	-0.14	-0.13	0.41	-0.07	-0.15	-0.13	-0.13	0.41	-0.12	-0.08	-0.14	0.18		0.15	0.14	0.18	-0.13	-0.5	-0.09	-0.08
Good Will	0.5	0.49	0.23	-0.4	-0.55	0.47	0.46	0.44	0.0	0.43	0.53	0.55	0.45	0.02	0.37	0.16	0.51	0.86	0.15		0.51	0.79	0.54	-0.87	0.33	0.29
Other Current Assets	0.19	0.6	-0.27	-0.11	-0.24	0.46	0.18	0.16	0.34	0.18	0.2	0.54	0.17	0.35	0.7	-0.29	0.24	0.33	0.14	0.51		0.28	0.21	-0.59	-0.09	-0.17
Intangible Assets	-0.02	0.09	-0.1	0.13	0.03	0.59	-0.08	-0.08	0.21	-0.01	-0.03	0.06	-0.08	0.21	0.12	-0.19	-0.04	0.99	0.18	0.79	0.28		-0.02	-0.55	-0.12	-0.13
Short Long Term Debt Total	0.92	0.58	0.74	-0.93	-0.98	-0.18	0.94	0.92	-0.38	0.76	1.0	0.73	0.92	-0.35	0.19	0.73	0.97	0.09	-0.13	0.54	0.21	-0.02		-0.58	0.86	0.83
Property Plant And Equipment Net	-0.5	-0.53	-0.2	0.44	0.59	-0.49	-0.49	-0.46	-0.03	-0.46	-0.56	-0.59	-0.47	-0.04	-0.41	-0.15	-0.54	-0.63	-0.5	-0.87	-0.59	-0.55	-0.58		-0.33	-0.28
Net Invested Capital	0.92	0.36	0.95	-0.79	-0.81	-0.55	0.91	0.93	-0.21	0.71	0.88	0.54	0.93	-0.18	-0.16	0.95	0.9	-0.04	-0.09	0.33	-0.09	-0.12	0.86	-0.33		0.98
Net Working Capital	0.86	0.21	0.96	-0.82	-0.78	-0.6	0.88	0.87	-0.17	0.73	0.84	0.43	0.87	-0.15	-0.28	0.96	0.84	-0.05	-0.08	0.29	-0.17	-0.13	0.83	-0.28	0.98

Click cells to compare fundamentals

Biovie Account Relationship Matchups

Biovie fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.1M	6.0M	20.1M	35.1M	40.4M	42.4M
Total Current Liabilities	23.5M	996.4K	4.2M	14.5M	16.7M	17.5M
Total Stockholder Equity	(21.5M)	5.1M	3.7M	15.3M	17.6M	18.5M
Net Debt	873.8K	(4.5M)	(6.4M)	(5.0M)	(4.5M)	(4.3M)
Retained Earnings	(41.0M)	(224.9M)	(251.0M)	(301.2M)	(271.1M)	(257.5M)
Accounts Payable	1.3M	996.4K	2.4K	3.5K	4.0K	3.8K
Cash	37.2K	4.5M	18.6M	19.5M	22.4M	23.5M
Cash And Short Term Investments	37.2K	4.5M	18.6M	33.9M	39.0M	41.0M
Common Stock Total Equity	50.7K	520.0	2.2K	2.5K	2.2K	2.1K
Liabilities And Stockholders Equity	2.1M	6.0M	20.1M	35.1M	40.4M	42.4M
Non Current Liabilities Total	62.5K	0.0	12.3M	5.3M	6.1M	6.4M
Other Stockholder Equity	19.5M	229.9M	254.6M	316.4M	363.8M	382.0M
Total Liab	23.6M	996.4K	16.4M	19.8M	22.7M	23.9M
Total Current Assets	413.0K	4.6M	18.8M	34.0M	39.1M	41.1M
Common Stock	520.0	2.2K	2.5K	3.6K	3.3K	3.1K
Other Current Liab	21.4M	996.4K	4.1M	5.3M	6.1M	3.7M
Net Tangible Assets	(23.2M)	3.6M	2.5M	14.4M	16.5M	17.3M
Common Stock Shares Outstanding	4.9M	12.4M	24.7M	32.5M	37.4M	39.2M
Non Current Assets Total	1.7M	1.4M	1.3M	1.1M	957.2K	1.3M
Other Current Assets	375.8K	93.5K	137.9K	102.5K	117.9K	128.7K
Intangible Assets	1.3M	1.1M	866.5K	637.1K	573.4K	1.0M
Net Invested Capital	(20.6M)	5.1M	15.8M	29.7M	34.1M	35.8M
Net Working Capital	(23.1M)	3.6M	14.6M	19.5M	22.5M	23.6M
Capital Stock	520.0	2.2K	2.5K	3.6K	3.3K	3.1K

Pair Trading with Biovie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biovie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biovie Stock

0.63

JNJ

Johnson Johnson Financial Report 18th of July 2024

Pair Corr

Moving against Biovie Stock

0.77	NUVB	Nuvation Bio Financial Report 2nd of May 2024	Pair Corr
0.54	IMMP	Immutep Ltd ADR	Pair Corr
0.51	MRKR	Marker Therapeutics	Pair Corr

The ability to find closely correlated positions to Biovie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biovie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biovie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biovie Inc to buy it.

The correlation of Biovie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biovie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biovie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biovie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:

How To Invest In Biovie

Details

Is Biovie Stock a good investment?

Details

What is Biovie's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.

	Commodity Directory Find actively traded commodities issued by global exchanges
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.

Is Biovie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.17)

Return On Assets

(0.81)

Return On Equity

(2.58)

The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biovie Book Value per Share vs Working Capital Analysis

Book Value Per Share vs Working Capital

Book Value per Share vs Working Capital Correlation Analysis

Correlation Coefficient

Book Value Per Share

Working Capital

Biovie fundamental ratios Correlations

Biovie Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biovie fundamental ratios Accounts

Pair Trading with Biovie

Moving together with Biovie Stock

Moving against Biovie Stock

Complementary Tools for Biovie Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Short Long Term Debt Total	+ 1.0	Other Stockholder Equity

Short Long Term Debt Total	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Cash	- 0.93	Retained Earnings
Short Long Term Debt Total	- 0.93	Net Debt
Other Stockholder Equity	- 0.92	Net Debt